Harvard Medical School Neuromuscular Medicine (Neurology)

Topics

• Amyotrophic Lateral Sclerosis Research 397
• Neurogenetic and Muscular Disorders Research 169
• Muscle Physiology and Disorders 116
• Inflammatory Myopathies and Dermatomyositis 87
• Cervical and Thoracic Myelopathy 80
• Myasthenia Gravis and Thymoma 71
• Peripheral Neuropathies and Disorders 71
• Hereditary Neurological Disorders 44
• Genetic Neurodegenerative Diseases 35
• Peripheral Nerve Disorders 24
• Spinal Cord Injury Research 23
• Autism Spectrum Disorder Research 18

Most cited

1. Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.

   The New England journal of medicine · 2022 · 755 citations · Suma Babu

2. Spinal muscular atrophy.

   Nature reviews. Disease primers · 2022 · 355 citations · Basil Darras

3. A Clinical Practice Guideline for the Management of Patients With Acute Spinal Cord Injury: Recommendations on Hemodynamic Management.

   Global spine journal · 2024 · 85 citations · Lindsay Tetreault

4. Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial.

   The Lancet. Neurology · 2021 · 399 citations · Basil Darras, Perry Shieh

5. Risdiplam in Type 1 Spinal Muscular Atrophy.

   The New England journal of medicine · 2021 · 347 citations · Basil Darras

6. Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial.

   Nature medicine · 2022 · 263 citations ·